These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15554160)

  • 1. Successful utilization of lyophilized lipoprotein(a) as a biological reagent.
    Scanu AM; Hinman J; Pfaffinger D; Edelstein C
    Lipids; 2004 Jun; 39(6):589-93. PubMed ID: 15554160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) in health and disease.
    Kronenberg F; Steinmetz A; Kostner GM; Dieplinger H
    Crit Rev Clin Lab Sci; 1996; 33(6):495-543. PubMed ID: 8989507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of human free apolipoprotein(a) and lipoprotein(a) after either freezing or lyophilization in the presence and absence of cryopreservatives.
    Edelstein C; Hinman J; Marcovina S; Scanu AM
    Anal Biochem; 2001 Jan; 288(2):201-8. PubMed ID: 11152591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of a stable fresh frozen primary lipoprotein[a] (Lp[a]) standard.
    Kostner GM; Ibovnik A; Holzer H; Grillhofer H
    J Lipid Res; 1999 Dec; 40(12):2255-63. PubMed ID: 10588951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
    Merki E; Graham MJ; Mullick AE; Miller ER; Crooke RM; Pitas RE; Witztum JL; Tsimikas S
    Circulation; 2008 Aug; 118(7):743-53. PubMed ID: 18663084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular risk.
    Discepolo W; Wun T; Berglund L
    Pathophysiol Haemost Thromb; 2006; 35(3-4):314-21. PubMed ID: 16877880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) catabolism: a case of multiple receptors.
    McCormick SPA; Schneider WJ
    Pathology; 2019 Feb; 51(2):155-164. PubMed ID: 30595508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a).
    Marcovina SM; Albers JJ; Scanu AM; Kennedy H; Giaculli F; Berg K; Couderc R; Dati F; Rifai N; Sakurabayashi I; Tate JR; Steinmetz A
    Clin Chem; 2000 Dec; 46(12):1956-67. PubMed ID: 11106328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of Lp(a) measurements.
    Kostner GM; Steinmetz A
    Clin Genet; 1997 Nov; 52(5):393-7. PubMed ID: 9520132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalysis of covalent Lp(a) assembly: evidence for an extracellular enzyme activity that enhances disulfide bond formation.
    Becker L; Nesheim ME; Koschinsky ML
    Biochemistry; 2006 Aug; 45(32):9919-28. PubMed ID: 16893192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fibrinolysis by lipoprotein(a).
    Anglés-Cano E; de la Peña Díaz A; Loyau S
    Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a): a unique risk factor for cardiovascular disease.
    Anuurad E; Boffa MB; Koschinsky ML; Berglund L
    Clin Lab Med; 2006 Dec; 26(4):751-72. PubMed ID: 17110238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay--Lp(a) SRM 2B.
    Dati F; Tate JR; Marcovina SM; Steinmetz A; ;
    Clin Chem Lab Med; 2004; 42(6):670-6. PubMed ID: 15259385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherothrombogenicity of lipoprotein(a): the debate.
    Scanu AM
    Am J Cardiol; 1998 Nov; 82(9A):26Q-33Q. PubMed ID: 9819101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lipoprotein(a) and LDL on plasminogen binding to extracellular matrix and on matrix-dependent plasminogen activation by tissue plasminogen activator.
    Pekelharing HL; Kleinveld HA; Duif PF; Bouma BN; van Rijn HJ
    Thromb Haemost; 1996 Mar; 75(3):497-502. PubMed ID: 8701415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The unique lipoprotein(a): properties and immunochemical measurement.
    Albers JJ; Marcovina SM; Lodge MS
    Clin Chem; 1990 Dec; 36(12):2019-26. PubMed ID: 2253341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoprotein(a). Its importance as an additional atherosclerosis marker].
    Campos E
    Acta Med Port; 1997 Jan; 10(1):87-93. PubMed ID: 9245184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein composition of Lp(a) lipoprotein from human plasma.
    Utermann G; Weber W
    FEBS Lett; 1983 Apr; 154(2):357-61. PubMed ID: 6219896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Lp(a) standardization.
    Labeur C; Rosseneu M; Henderson O
    Chem Phys Lipids; 1994 Jan; 67-68():265-70. PubMed ID: 8187223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial expression and characterization of human recombinant apolipoprotein(a) kringle IV type 9.
    Chung FZ; Wu LH; Lee HT; Mueller WT; Spahr MA; Eaton SR; Tian Y; Settimi PD; Oxender DL; Ramharack R
    Protein Expr Purif; 1998 Jul; 13(2):222-8. PubMed ID: 9675066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.